Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs
Pre-operative plasma levels of soluble fibrin polymers correlate with the development of deep vein thrombosis after elective neurosurgery
Haemostatic parameters related to lipids and adhesion molecules
A protease isolated from human plasma activating Factor VII independent of tissue factor
Relationship between thyroid hormones and fibrinogen levels
Specific determination of plasmin inhibitor activity in plasma
Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood
ATIII-independence of anticoagulant effect of human urinary soluble thrombomodulin
Effects of sarpogrelate hydrochloride on platelet aggregation, and its relation to the release of serotonin and P-selectin
Small doses of recombinant factor Vila in acquired deficiencies of vitamin K dependent factors
Prothrombin 20210A and familial thrombophilia
British Society for Haemostasis and Thrombosis
O1 Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45–64 years
O2 Propagation of inactivation of antithrombin and the onset of thrombosis
O3 Heparin modulates the expression and release of tissue factor pathway inhibitor in human endothelial cells in culture
O4 Heparins sensitize platelets to responses mediated via both the P27 and the P2Y1 receptor pathways
05 Heparin versus blood component therapy in severe D.I.C with shock syndrome in the obstetric accidents (multi-centre trial)
06 The pulmonary embolism prevention (PEP) trial
07 The differential regulation of the endothelial protein C receptor (EPCR) and thrombomodulin by inflammatory cytokines
08 Dextran-40 stimulates resting platelets and binds preferentially to activated platelets
09 VWF-cleaving protease activity in congenital thrombotic thrombocytopenic purpura
O10 Circulating activated platelets in the acute and convalescent phases of thrombotic stroke
O11 The relationship of coagulation and endothelial cell activation to impairment of nerve function and blood flow in diabetic rats
O12 Prion protein distribution in blood and its release during storage of apheresis platelet concentrate
O13 The effect of acute smoking on platelet aggregometry and alpha granule degranulation
O14 Vascular endothelial growth factor (VEGF) and soluble VEGF receptor (sFlt-1) levels in coronary artery disease and peripheral artery disease
O15 Haemostatic cardiovascular risk factors in the WHO MONICA Project
Poster Session; P1 Acquired α2-antiplasmin deficiency, and deficient response to venous occlusion in late-pregnancy and preeclampsia
P2 Investigation of the factor XII gene by the use of Pfu proof reading polymerase in PCR
P3 2.6 Å Structure of beta antithrombin and complete structure of latent antithrombin
P4 Associations of menopause and different hormone replacement therapies with thrombotic variables and C-reactive protein
P5 Distribution of arachidonic acid in platelet phospholipids from patients with myeloproliferative disorders and non-insulin-dependent diabetes
P6 Heparin, cardiopulmonary bypass and neutrophil-platelet interaction
P7 The effect of a reducing end extension on pentasaccharide binding by antithrombin
P8 The differential effect of low-molecular-weight and unfractioned heparin on capillary structure formation
P9 Accuracy and precision of measurements of heparin concentrations by heparin management system during cardiac surgery
P10 Utility of prothrombin time waveform analysis in the routine clinical setting
P11 Coagulation activation markers in SLE and primary antiphospholipid syndrome (PAPS)
P12 Blood coagulation inhibitor detected specifically by human recombinant thromboplastins
P13 The effect of resistance exercise and training on blood haemostasis in men
P14 Factor XII deficiency associated with a bleeding tendency?
P15 Increased levels of soluble P selectin, a marker of platelet activation, in solid and haematological cancer
P16 Structural insights into the heparin activation of antithrombin
P17 Effect of exacerbation on plasma levels of tissue factor in patients with COPD
A note of thanks to referees
Author index to Volume 10 1999